Literature DB >> 30471020

A case report of Fisher syndrome with the detection of anti-GM3 and anti-GD1b IgG antibodies.

Kosuke Matsuzono1, Tadashi Ozawa2, Keisuke Yoshikawa3, Susumu Kusunoki3, Shigeru Fujimoto2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30471020     DOI： 10.1007/s10072-018-3655-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  8 in total

1.  Clinical features and prognosis of Miller Fisher syndrome.

Authors:  M Mori; S Kuwabara; T Fukutake; N Yuki; T Hattori
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

2.  Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody.

Authors:  C L Pan; N Yuki; M Koga; M C Chiang; S T Hsieh
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

3.  Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.

Authors:  S Kusunoki; M Shiina; I Kanazawa
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

Review 4.  Peripheral neuropathies and anti-glycolipid antibodies.

Authors:  Hugh J Willison; Nobuhiro Yuki
Journal:  Brain       Date:  2002-12       Impact factor: 13.501

5.  Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum.

Authors:  Masafumi Ito; Kenjiro Matsuno; Yasuhiko Sakumoto; Koichi Hirata; Nobuhiro Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-20       Impact factor: 10.154

6.  Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia.

Authors:  S Kusunoki; A Chiba; I Kanazawa
Journal:  Muscle Nerve       Date:  1999-08       Impact factor: 3.217

7.  GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.

Authors:  K Kaida; K Kamakura; G Ogawa; M Ueda; K Motoyoshi; M Arita; S Kusunoki
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

8.  Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.

Authors:  Anna-Helena Saariaho; Arja Vuorela; Tobias L Freitag; Fabio Pizza; Giuseppe Plazzi; Markku Partinen; Outi Vaarala; Seppo Meri
Journal:  J Autoimmun       Date:  2015-07-27       Impact factor: 7.094
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.